Idiopathic Juxtafoveal Telangiectasia Type II (Macular …
网页2014年2月17日 · Idiopathic juxtafoveal telangiectasia (IJFT), also known as idiopathic macular telangiectasia [1], is an uncommon disorder characterized by telangiectatic vessels in the juxtafoveolar region of one or both eyes. According to Gass, IJFT can be divided into three groups based upon phenotype: [2] type I is typically a unilateral disease ...
Atlas Entry - Idiopathic juxtafoveal telangiectasia - University of Iowa
网页Photographer: Brice Critser, CRA. Idiopathic juxtafoveal telangiectasia type II (aka macular telangiectasia) is a rare idiopathic condition that is characterized by telangiectatic vessels in the juxtafoveolar region, most commonly temporal to the fovea, of both eyes. Additional findings include graying of the parafoveal retina, superficial ...
EyeRounds.org: Ocular Ischemic Syndrome - University of Iowa
网页2022年7月26日 · Ocular perfusion pressure is considered a function of the arterial pressure reaching the eye minus the intraocular pressure (ocular perfusion pressure [OPP] = mean arterial pressure [MAP] – intraocular pressure [IOP]). To understand ocular ischemic syndrome, it is important to know the anatomy of blood flow from the heart to the eye.
网页Version: Oct. 10, 2000 EVALUATION OF STUDY EYE PHOTOGRAPHS: PERIPAPILLARY ZONE P-1. Retinal hemorrhage P-2. Subretinal hemorrhage P-3. Preretinal hemorrhage Vitreous hemorrhage P-5. Optic disc hemorrhage P-6. Vascular sheathing P-7. Cotton wool P-8. P-9. Telangiectasia P-10. Neovascularization of d isc P-II. Optic disc edema P-12. …
网页2010年7月7日 · Pathophysiology. A retinal artery macroaneurysm (RAMA) is usually described as an idiopathic, acquired dilation of a major retinal arteriole. Typically these develop within its first three bifurcations, at branch points, or areas of arteriovenous crossing. The most commonly reported site for RAMAs is the superotemporal arteriole.
Branch Retinal Vein Occlusion - University of Iowa
网页2018年7月20日 · The 2010 Branch Retinal Vein Occlusion (BRAVO) study examined the outcomes of intravitreal anti-VEGF injections for treatment of BRVO [12]. In this randomized, sham injection-controlled clinical trial, patients with BRVO-associated CME received intraocular injections of 0.3 mg or 0.5 mg ranibizumab (Lucentis®).
Coats Disease - University of Iowa
网页2016年6月30日 · Figure 7: Left Eye, OCT of the macula 5 months after presentation showing improved macular edema after intravitreal bevacizumab. DIAGNOSIS . Coats Disease. DISCUSSION Etiology/Pathophysiology. Coats disease was first described by Dr. George Coats in 1908.[1] The definition of the disease has since been refined by Reese in 1956 …
Macular Hole, Full-Thickness, Extrafoveal/Eccentric - University of …
网页2014年5月4日 · ILM peeling is sometimes done at the time of macular hole repair, epiretinal membrane removal, and retinal detachment repair. Complications can include focal retinal hemorrhages and edema. Direct mechanical trauma can cause nerve fiber layer damage, and iatrogenic eccentric full-thickness retinal breaks and/or holes as shown in this case.
Hydroxychloroquine (Plaquenil) Toxicity and Recommendations …
网页2011年8月30日 · Baseline visual field and SD OCT are recommended if abnormalities are present (e.g. macular lesions, glaucoma, etc) that could affect screening tests. Annual Screening: The risk of toxicity is rare in the first several years of treatment with HCQ and CQ. In the absence of major risk factors, screening can be postponed for 5 years.
Integrated Systemic Inflammation and AI-Driven OCT Metrics in ...
网页2024年8月2日 · Results: 10-fold cross-validation yielded high R 2 of 0.85, 0.95, and 0.89 for predicted vs ground truth of OCT quantified IRF, SRF, and PED volumes, respectively. Flow cytometry showed that patients with high-risk MMP9 genotype have CD4 T cells with a trend (p=0.051) toward greater capacity to generate IL-4 and IL-13, both of which are major ...